These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 18343785)

  • 1. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.
    Mahooti S; Porter K; Alpaugh ML; Ye Y; Xiao Y; Jones S; Tellez JD; Barsky SH
    Oncotarget; 2010 Jun; 1(2):131-147. PubMed ID: 21297224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Tumor Budding and Patient's Survival in Breast Cancer.
    Ranaee M; Torabi H; Azhganzad N; Shirini K; Hosseini AS; Hajian K
    Clin Pathol; 2024; 17():2632010X241235543. PubMed ID: 38487273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Usefulness of Elastin Staining to Detect Vascular Invasion in Cancer.
    Gonzalez J; Bahmad HF; Ocejo S; Abreu A; Popp M; Gogola S; Fernandez V; Recine M; Poppiti R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoacoustic imaging provides an in vivo assessment of the preeclamptic placenta remodeling and function in response to therapy.
    Lawrence DJ; Bayer CL
    Placenta; 2022 Aug; 126():46-53. PubMed ID: 35764022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
    Yadav K; Lim J; Choo J; Ow SGW; Wong A; Lee M; Chan CW; Hartman M; Lim SE; Ngoi N; Tang SW; Ang Y; Chan G; Chong WQ; Tan HL; Tan SH; Goh BC; Lee SC
    Breast Cancer Res Treat; 2022 Feb; 192(1):131-142. PubMed ID: 34928481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and Clinical Significance of Tumor Lymphatic Invasion.
    Fujimoto N; Dieterich LC
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time density curve of dynamic contrast-enhanced computed tomography correlates with histological characteristics of pancreatic cancer.
    Goto S; Seino H; Yoshizawa T; Morohashi S; Ishido K; Hakamada K; Kijima H
    Oncol Lett; 2021 Apr; 21(4):276. PubMed ID: 33732352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonographic Algorithm for the Assessment of Sentinel Lymph Nodes That Drain the Mammary Carcinomas in Female Dogs.
    Stan F; Gudea A; Damian A; Gal AF; Papuc I; Pop AR; Martonos C
    Animals (Basel); 2020 Dec; 10(12):. PubMed ID: 33321917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Deep Learning Model to Identify Lymph Node Metastasis on Magnetic Resonance Imaging in Patients With Cervical Cancer.
    Wu Q; Wang S; Zhang S; Wang M; Ding Y; Fang J; Wu Q; Qian W; Liu Z; Sun K; Jin Y; Ma H; Tian J
    JAMA Netw Open; 2020 Jul; 3(7):e2011625. PubMed ID: 32706384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.
    Pak KH; Park KC; Cheong JH
    BMC Cancer; 2019 Aug; 19(1):799. PubMed ID: 31409309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas.
    Widodo I; Dwianingsih EK; Utoro T; Anwar SL; Aryandono T; Soeripto S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2461-2467. PubMed ID: 30255700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Adipose Tissue to Development of Cancer.
    Cozzo AJ; Fuller AM; Makowski L
    Compr Physiol; 2017 Dec; 8(1):237-282. PubMed ID: 29357128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer.
    Zhang S; Zhang D; Gong M; Wen L; Liao C; Zou L
    BMC Cancer; 2017 May; 17(1):335. PubMed ID: 28514957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.
    Niemiec JA; Adamczyk A; Ambicka A; Mucha-Małecka A; Wysocki WM; Biesaga B; Ziobro M; Cedrych I; Grela-Wojewoda A; Domagała-Haduch M; Wysocka J; Ryś J; Sas-Korczyńska B
    Am J Transl Res; 2017; 9(3):1435-1447. PubMed ID: 28386369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritumoral lymphatic vessel density and invasion detected with immunohistochemical marker D240 is strongly associated with distant metastasis in breast carcinoma.
    Norhisham NF; Chong CY; Safuan S
    BMC Clin Pathol; 2017; 17():2. PubMed ID: 28203117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral and peritumoral lymphatic vessel density both correlate with lymph node metastasis in breast cancer.
    Zhang S; Yi S; Zhang D; Gong M; Cai Y; Zou L
    Sci Rep; 2017 Jan; 7():40364. PubMed ID: 28067327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and meta-analysis.
    Zhang S; Zhang D; Yi S; Gong M; Lu C; Cai Y; Tang X; Zou L
    Oncotarget; 2017 Jan; 8(2):2863-2873. PubMed ID: 27926511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis.
    Martínez-Iglesias O; Olmeda D; Alonso-Merino E; Gómez-Rey S; González-López AM; Luengo E; Soengas MS; Palacios J; Regadera J; Aranda A
    Oncotarget; 2016 Nov; 7(48):78971-78984. PubMed ID: 27806339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer.
    Wong AL; Sundar R; Wang TT; Ng TC; Zhang B; Tan SH; Soh TI; Pang AS; Tan CS; Ow SG; Wang L; Mogro J; Ho J; Jeyasekharan AD; Huang Y; Thng CH; Chan CW; Hartman M; Iau P; Buhari SA; Goh BC; Lee SC
    Oncotarget; 2016 Sep; 7(39):64089-64099. PubMed ID: 27577069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.